GlassScriptPhysician profile
Mary Lack
NPI 1801882535
$2,757.57
in general payments reported to CMS, 2019-2025
17 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $95.57 · 2021: $244 · 2022: $571 · 2023: $453 · 2024: $675 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,471.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $398.77 | 2019-2024 | Acuvue |
| Bausch & Lomb Americas INC. | $352.54 | 2022-2024 | Infuse, Xiidra, Miebo |
| Coopervision INC. | $322.21 | 2019-2023 | Misight Contact Lens |
| Allergan, INC. | $239.22 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $224.96 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $217.84 | 2022-2025 | Precision7 |
| Amgen INC. | $185.75 | 2024-2025 | Tepezza |
| Novartis Pharmaceuticals Corporation | $164.75 | 2020-2022 | |
| Abbvie INC. | $149.17 | 2022-2024 | |
| Sun Pharmaceutical Industries INC. | $106.46 | 2021-2025 | Cequa |
| Oyster Point Pharma, INC. | $106.43 | 2022-2025 | Tyrvaya |
| Biotissue Holdings INC. | $95.06 | 2021-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $61.48 | 2019-2020 | |
| Thea Pharma INC. | $39.89 | 2022-2023 | Iyuzeh |
| Shire North American Group INC | $39.60 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $38.49 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $14.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Lack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.